Reversible Alopecia Universalis Secondary to PEG-Interferon Alpha-2b and Ribavirin Combination Therapy in a Patient with Chronic Hepatitis C Virus Infection

    Elif Doyuk Kartal, Saygın Nayman Alpat, İlhan Özgüneş, Gaye Usluer
    Studysummary This case report documents a reversible instance of complete body hair loss (alopecia universalis) in a patient undergoing chronic hepatitis C treatment with pegylated interferon alpha-2b and ribavirin, with hair regrowth observed within three months after therapy completion.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on journals.lww.com →
    Discuss this study in the Community →

    Research cited in this study 6

    1. Telogen Effluvium Due to Recombinant Interferon Alpha-2b Dermatology · 2009
    2. Reversible Alopecia Universalis During Treatment with PEG-Interferon and Ribavirin for Chronic Hepatitis C Journal of Chemotherapy · 2005
    3. Case Report: Diffuse Hypertrichosis in the Course of Hepatitis C Treatment by IFN-Alpha and Ribavirin Journal of Interferon and Cytokine Research · 2002
    4. Straight Hair Associated with Interferon-Alpha Plus Ribavirin in Hepatitis C Infection British Journal of Dermatology · 2002
    5. Alopecia Areata During Interferon Alpha-2b and Ribavirin Therapy Dermatology · 2002
    6. Effects of Cytokines, Anti-Cancer Agents, and Cocarcinogen on DNA Synthesis in Hair Bulb Cells Journal of Dermatological Science · 1993